Francisco Exposito

12PUBLICATIONS
57CO-AUTHORS
Predictive and prognostic markersMolecular targetsInnate immunityLiquid biopsiesTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 27, 2026
Loss of PTEN as an Independent Poor Prognosis Indicator in Lung Adenocarcinoma, but Not in Squamous Cell Carcinoma, Is Associated with an Immunosuppressive Tumor Microenvironment and Distinct Co-Mutational Profiles.

|Nov 25, 2024
Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancer.

Camila Robles-Oteíza, Katherine Hastings, Jungmin Choi

|Nov 03, 2024
G9a/DNMT1 co-targeting inhibits non-small cell lung cancer growth and reprograms tumor cells to respond to cancer-drugs through SCARA5 and AOX1.

Francisco Exposito, Miriam Redrado, Diego Serrano

|Jun 28, 2023
Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer.

Nerea Otegui, Maeva Houry, Imanol Arozarena

|Jun 13, 2023
PTEN Loss Confers Resistance to Anti-PD-1 Therapy in Non-Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells.

Francisco Exposito, Miriam Redrado, Maeva Houry

|Feb 05, 2022
Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade.

Daniel Ajona, Sergio Ortiz-Espinosa, Teresa Lozano

Pageof 2

Frequent Collaborators

5 joint publications

Alfonso Calvo

5 joint publications

Luis Montuenga

4 joint publications

Miriam Redrado

4 joint publications

Diego Serrano